EX-10.2 3 srne-ex102_151.htm EX-10.2 EXECUTION VERSION STOCK PURCHASE AGREEMENT by and among TNK Therapeutics, Inc., BDL Products, Inc. The Stockholders of BDL Products, Inc., Richard Junghans, M.D., PH.D., as the Stockholders’ Representative And,...Stock Purchase Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionTHIS STOCK PURCHASE AGREEMENT is made and entered into as of August 7, 2015, by and among TNK Therapeutics, Inc., a Delaware corporation (the “Purchaser”), BDL Products, Inc., a Delaware corporation (the “Company”), the stockholders of the Company set forth on the signature pages to this Agreement (collectively, the “Stockholders” and, individually, a “Stockholder”), Richard P. Junghans, M.D., Ph.D., an individual resident of 1 Lyndboro Place, Boston, Massachusetts 02116 , as representative of the Stockholders pursuant to Article XI (the “Stockholders’ Representative”), and, solely with respect to Sections 1.6 and 1.7 and Article XII, Sorrento Therapeutics Inc., a Delaware corporation (“Sorrento”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 16th, 2015 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • California
Contract Type FiledNovember 16th, 2015 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT is made and entered into as of August 7, 2015, by and among TNK Therapeutics, Inc., a Delaware corporation (the “Purchaser”), BDL Products, Inc., a Delaware corporation (the “Company”), the stockholders of the Company set forth on the signature pages to this Agreement (collectively, the “Stockholders” and, individually, a “Stockholder”), Richard P. Junghans, M.D., Ph.D., an individual resident of 1 Lyndboro Place, Boston, Massachusetts 02116 , as representative of the Stockholders pursuant to Article XI (the “Stockholders’ Representative”), and, solely with respect to Sections 1.6 and 1.7 and Article XII, Sorrento Therapeutics Inc., a Delaware corporation (“Sorrento”).